Literature DB >> 8898350

The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease.

L K Smith1, K M Rice, C W Garner.   

Abstract

Insulin receptor substrate-1 (IRS-1) is a protein expressed in 3T3-L1 adipocytes that is involved in most, if not all of the biological responses to insulin. Chronic exposure of these cells to insulin down-regulates IRS-1 by stimulating its degradation (Rice, K.M., Turnbow, M.A. and Garner, C.W. (1993) Biochem. Biophys. Res. Commun. 190, 961-967). This insulin-induced down-regulation of IRS-1 was totally abolished by BAPTA-AM (cell-permeable calcium chelator), E-64d (cell-permeable thiol protease inhibitor), Cbz-Leu-Nleu-H and Cbz-Leu-Leu-Tyr-CHN2 (selective cell-permeable calpain inhibitor peptides). Calpastatin (specific calpain inhibitor protein) also inhibited the insulin-induced down-regulation of IRS-1 in transiently permeabilized cells. In addition, 3T3-L1 adipocytes express endogenous calpain which can degrade IRS-1 in cell-free extracts. These results suggest that the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease which is sensitive to inhibition by calpain inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898350     DOI: 10.1016/0303-7207(96)03875-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress.

Authors:  R Potashnik; A Bloch-Damti; N Bashan; A Rudich
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

2.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.

Authors:  A V Lee; J L Gooch; S Oesterreich; R L Guler; D Yee
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  A novel domain mediates insulin-induced proteasomal degradation of insulin receptor substrate 1 (IRS-1).

Authors:  Sigalit Boura-Halfon; Timor Shuster-Meiseles; Avital Beck; Katia Petrovich; Diana Gurevitch; Denise Ronen; Yehiel Zick
Journal:  Mol Endocrinol       Date:  2010-09-15

Review 5.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

6.  GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.

Authors:  T P Ciaraldi; L Carter; S Mudaliar; R R Henry
Journal:  Mol Cell Endocrinol       Date:  2009-06-06       Impact factor: 4.102

Review 7.  Role of calpains in diabetes mellitus: a mini review.

Authors:  Fredrick Harris; Lee Chatfield; Jaipaul Singh; David A Phoenix
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

8.  Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.

Authors:  Xiangkun Meng; Zhe Huang; Aiko Inoue; Hailong Wang; Ying Wan; Xueling Yue; Shengnan Xu; Xueying Jin; Guo-Ping Shi; Masafumi Kuzuya; Xian Wu Cheng
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-30       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.